These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 30759713)
1. Re: The Temporal Association of Robotic Surgical Diffusion with Overtreatment of the Small Renal Mass: P. H. Shah, M. A. Alom, B. C. Leibovich, R. H. Thompson, R. G. Uzzo, L. R. Kavoussi, L. Richstone, B. Bhindi, E. B. Habermann, V. Joshi and S. A. BoorjianJ Urol 2018; 200: 981-988. Neves JB; Tran MGB J Urol; 2019 Mar; 201(3):626-627. PubMed ID: 30759713 [No Abstract] [Full Text] [Related]
2. Re: The Temporal Association of Robotic Surgical Diffusion with Overtreatment of the Small Renal Mass. Veccia A; Derweesh IH; Antonelli A; Autorino R Eur Urol; 2019 May; 75(5):877-878. PubMed ID: 30728098 [No Abstract] [Full Text] [Related]
3. Positive Surgical Margins Increase Risk of Recurrence after Partial Nephrectomy for High Risk Renal Tumors. Shah PH, Moreira DM, Okhunov Z, Patel VR, Chopra S, Razmaria AA, Alom M, George AK, Yaskiv O, Schwartz MJ, Desai M, Vira MA, Richstone L, Landman J, Shalhav AL, Gill I, Kavoussi LR. J Urol. 2016 Aug;196(2):327-34. Kryvenko ON Urol Oncol; 2017 Jun; 35(6):449-450. PubMed ID: 28416109 [TBL] [Abstract][Full Text] [Related]
4. Re: Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy R. H. Thompson, S. A. Boorjian, C. M. Lohse, B. C. Leibovich, E. D. Kwon, J. C. Cheville and M. L. Blute J Urol 2008; 179: 468-473. Bhandari M; Siva S J Urol; 2008 Oct; 180(4):1568-9; author reply 1569. PubMed ID: 18718608 [No Abstract] [Full Text] [Related]
5. Re: Variation in Surgical Margin Status by Surgical Approach among Patients Undergoing Partial Nephrectomy for Small Renal Masses: W. Tabayoyong, R. Abouassaly, J. E. Kiechle, E. E. Cherullo, N. J. Meropol, N. D. Shah, S. Dong, R. H. Thompson, M. C. Smaldone, H. Zhu, S. Ialacci and S. P. Kim J Urol 2015;194:1548-1553. Bhattar R; Yadav SS; Priyadarshi S; Tomar V J Urol; 2016 Sep; 196(3):960. PubMed ID: 27311408 [No Abstract] [Full Text] [Related]
6. Re: Severity of Preoperative Proteinuria is a Risk Factor for Overall Mortality in Patients Undergoing Nephrectomy: D. Y. Yang, R. H. Thompson, H. B. Zaid, C. M. Lohse, A. D. Rule, S. A. Boorjian, B. C. Leibovich, J. C. Cheville and M. K. Tollefson J Urol 2017;198:795-802. Gul D; Cimen HI; Gokce A J Urol; 2018 Jun; 199(6):1631. PubMed ID: 29555545 [No Abstract] [Full Text] [Related]
7. The Temporal Association of Robotic Surgical Diffusion with Overtreatment of the Small Renal Mass. Shah PH; Alom MA; Leibovich BC; Thompson RH; Uzzo RG; Kavoussi LR; Richstone L; Bhindi B; Habermann EB; Joshi V; Boorjian SA J Urol; 2018 Nov; 200(5):981-988. PubMed ID: 29792881 [TBL] [Abstract][Full Text] [Related]
8. Re: The impact of ischemia time during open nephron sparing surgery on solitary kidneys: a multi-institutional study: R. H. Thompson, I. Frank, C. M. Lohse, I. R. Saad, A. Fergany, H. Zincke, B. C. Leibovich, M. L. Blute and A. C. Novick. J Urol 2007; 177: 471-476. Richstone L; Kavoussi LR J Urol; 2007 Sep; 178(3 Pt 1):1119; author reply 1119-20. PubMed ID: 17640684 [No Abstract] [Full Text] [Related]
9. Reply to Patrick O. Richard, Micheal A.S. Jewett and Antonio Finelli's Letter to the Editor re: Alexander Kutikov, Marc C. Smaldone, Robert G. Uzzo, Miki Haifler, Gennady Bratslavsky, Bradley C. Leibovich. Renal Mass Biopsy: Always, Sometimes, or Never? Eur Urol 2016;70:403-6. Kutikov A; Uzzo RG; Smaldone MC; Haifler M; Bratslavsky G; Leibovich BC Eur Urol; 2017 Feb; 71(2):e47-e48. PubMed ID: 27436159 [No Abstract] [Full Text] [Related]
10. Re: outcome of stage T2 or greater renal cell cancer treated with partial nephrectomy: R. H. Breau, P. L. Crispen, R. E. Jimenez, C. M. Lohse, M. L. Blute and B. C. Leibovich J Urol 2010; 183: 903-908. Cimen HI; Canda AE; Balbay MD J Urol; 2010 Nov; 184(5):2212; author reply 2212-3. PubMed ID: 20864129 [No Abstract] [Full Text] [Related]
11. Re: comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis: s. P. Kim, R. H. Thompson, s. A. Boorjian, C. J. Weight, L. C. Han, m. H. Murad, N. D. Shippee, p. J. Erwin, B. A. Costello, g. K. Chow and B. C. Leibovich j urol 2012; 188: 51-57. MacLennan S; Lam T; Imamura M; Dahm P; Canfield S; Ljungberg B; N'Dow J J Urol; 2013 Mar; 189(3):1166-7. PubMed ID: 23085051 [No Abstract] [Full Text] [Related]
12. Re: Robotic Level III Inferior Vena Cava Tumor Thrombectomy: Initial Series: I. S. Gill, C. Metcalfe, A. Abreu, V. Duddalwar, S. Chopra, M. Cunningham, D. Thangathurai, O. Ukimura, R. Satkunasivam, A. Hung, R. Papalia, M. Aron, M. Desai and M. Gallucci J Urol 2015;194:929-938. Yadav P; Vashishtha S; Mandhani A J Urol; 2016 Aug; 196(2):622-3. PubMed ID: 27156908 [No Abstract] [Full Text] [Related]
13. Re: Outcomes following partial nephrectomy by tumor size P. L. Crispen, S. A. Boorjian, C. M. Lohse, T. S. Sebo, J. C. Cheville, M. L. Blute and B. C. Leibovich J Urol 2008; 180: 1912-1917. Cimen HI; Serefoglu EC; Balbay MD J Urol; 2009 Sep; 182(3):1232; author reply 1232. PubMed ID: 19625039 [No Abstract] [Full Text] [Related]
14. Re: histological subtype is an independent predictor of outcome for patients with renal cell carcinoma: B. C. Leibovich, C. M. Lohse, P. L. Crispen, S. A. Boorjian, R. H. Thompson, M. L. Blute and J. C. Cheville J Urol 2010; 183: 1309–1316. Dogan B; Canda AE; Akbulut Z; Balbay MD J Urol; 2010 Nov; 184(5):2211; author reply 2211-2. PubMed ID: 20884030 [No Abstract] [Full Text] [Related]
15. Re: Hiury S. Andrade, Homayoun Zargar, Peter A. Caputo, et al. Five-year Oncologic Outcomes After Transperitoneal Robotic Partial Nephrectomy for Renal Cell Carcinoma. Eur Urol 2016;69:1149-54. Shin TY; Abdel Raheem A; Rha KH Eur Urol; 2016 Oct; 70(4):e100-e101. PubMed ID: 26995331 [No Abstract] [Full Text] [Related]
16. Re: Bimal Bhindi, E. Jason Abel, Laurence Albiges, et al. Systematic Review of the Role of Cytoreductive Nephrectomy in the Targeted Therapy Era and Beyond: An Individualized Approach to Metastatic Renal Cell Carcinoma. Eur Urol 2019;75:111-28: Cytoreductive Nephrectomy in the Targeted Therapy Era: This is Not the End. Massari F; Di Nunno V; Santoni M; Gatto L; Mollica V; Porta C Eur Urol Oncol; 2019 Sep; 2(5):603-604. PubMed ID: 31411982 [No Abstract] [Full Text] [Related]
18. Predictors of the Transition from Off to On Clamp Approach during Ongoing Robotic Partial Nephrectomy: Data from the CLOCK Randomized Clinical Trial. Antonelli A; Cindolo L; Sandri M; Annino F; Carini M; Celia A; D'Orta C; De Concilio B; Furlan M; Giommoni V; Ingrosso M; Mari A; Muto G; Nucciotti R; Porreca A; Primiceri G; Schips L; Sessa F; Simeone C; Veccia A; Minervini A; J Urol; 2019 Jul; 202(1):62-68. PubMed ID: 30827166 [TBL] [Abstract][Full Text] [Related]
19. Re: Raj Satkunasivam, Sheaumei Tsai, Sumeet Syan, et al. Robotic Unclamped "Minimal-margin" Partial Nephrectomy: Ongoing Refinement of the Anatomic Zero-ischemia Concept. Eur Urol 2015;68:705-12. Zu X; Qi L; Liu L Eur Urol; 2016 Apr; 69(4):e72-e73. PubMed ID: 26489477 [No Abstract] [Full Text] [Related]
20. Reply to Steven C. Campbell, Gopal N. Gupta, Robert G. Uzzo, Alexander Kutikov's Letter to the Editor re: Raj Satkunasivam, Sheaumei Tsai, Sumeet Syan, et al. Robotic Unclamped "Minimal-margin" Partial Nephrectomy: Ongoing Refinement of the Anatomic Zero-ischemia Concept. Eur Urol 2015;68:705-12. Satkunasivam R; Desai M; Gill IS Eur Urol; 2016 May; 69(5):e97-8. PubMed ID: 26385158 [No Abstract] [Full Text] [Related] [Next] [New Search]